Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Pharmaceutical Industry Infrastructure Overview

4. Pharmaceutical Market Outlook to 2017
     4.1 Market Size & Growth
     4.2 Branded and Generics Drugs
     4.3 Commercial Drugs Market
            4.3.1 Revenue by Anatomical Therapeutic Chemical (ATC) Classification System
            4.3.2 Leading Companies
            4.3.3 Leading Drugs
            4.3.4 Drugs Import Scenario
     4.4 State Segment
            4.4.1 Drug Reimbursement Program (DLO)
                       4.4.1.1 Revenue by Anatomical Therapeutic Chemical (ATC) Classification System
                       4.4.1.2 Leading Companies
                       4.4.1.3 Leading Drugs
                       4.4.1.4 Drugs Import Scenario
            4.4.2 Hospital Segment
                       4.4.2.1 Revenue by Anatomical Therapeutic Chemical (ATC) Classification System
                       4.4.2.2 Leading Companies
                       4.4.2.3 Leading Drugs
                       4.4.2.4 Drugs Import Scenario
     4.5 Parapharmaceutical Market
            4.5.1 Nutritional Supplements Market
            4.5.2 Leading Companies
            4.5.3 Drugs Import Scenario
     4.6 Pharmaceutical Distribution System

5. Clinical Trials Market Outlook

6. Industry Analysis
     6.1 Market Driving Forces
            6.1.1 Government Support for Industry Development
            6.1.2 Higher FDI Inflows
            6.1.3 Increasing Share of Expensive Drugs
            6.1.4 Rise in Purchasing Power: Better Affordability
     6.2 Industry Roadblocks

7. Regulatory Environment
     7.1 Current Reforms
     7.2 Objective and Impact of Proposed Laws and Legislations

8. Competitive Landscape
     8.1 Sanofi-Aventis
            8.1.1 Business Overview
            8.1.2 Product Portfolio
            8.1.3 Key Financials
            8.1.4 Strengths and Weaknesses
            8.1.5 Recent Developments
     8.2 Novartis Pharma ZAO
            8.2.1 Business Overview
            8.2.2 Product Portfolio
            8.2.3 Key Financials
            8.2.4 Strengths and Weaknesses
     8.3 Roche Moscow Ltd.
            8.3.1 Business Overview
            8.3.2 Product Portfolio
            8.3.3 Key Financials
            8.3.4 Strengths and Weaknesses
            8.3.5 Recent Developments
     8.4 Teva Pharmaceutical
            8.4.1 Business Overview
            8.4.2 Product Portfolio
            8.4.3 Key Financials
            8.4.4 Recent Developments
     8.5 Pharmstandard JSC
            8.5.1 Business Overview
            8.5.2 Product Portfolio
            8.5.3 Strengths and Weaknesses
            8.5.4 Recent Developments